CossartYEFieldAMCantBWiddowsD. Parvovirus-like particles in human sera. Lancet. 1975;1:72-73.
2.
YoungNMortimerP. Viruses and bone marrow failure. Blood. 1984;63:729-737.
3.
SerjeantGRSerjeantBEThomasPWAndersonMJPatouGPattisonJR. Human parvovirus infection in homozygous sickle cell disease. Lancet. 1993;341:1237-1240.
4.
AguiarFSLopesDPBazinARSetúbalSCohenBJNascimentoJP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop. 2001;34:239-242.
5.
WoolfADCampionGVChishickA. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989;149:1153-1156.
6.
SchwarzTFJägerGGilchS. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM. Zentralbl Bakteriol. 1997;285:525-530.
7.
EndersMWeidnerARosenthalT. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis. 2008;197:58-62.
8.
RotbartHA. Human parvovirus infections. Annu Rev Med. 1990;41:25-34.
9.
NunqueTKusuharaKHaraT. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. J Pediatr Infect Dis. 2002;21:1133-1136.
10.
NicolaidesKHSoothillPWClewellWHRodeckCHMibashanRSCampbellS. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet. 1988;1:1073-1075.
11.
YaegashiN. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med. 2000;190:65-82.
12.
TolfvenstamTPapadogiannakisNNorbeckOPeterssonKBrolidenK. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001;357:1494-1497.
13.
EndersMWeidnerAZoellnerISearleKEndersG. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004;24:513-518.
14.
SarafidisKDrossou-AgakidouVEvdoridouI. Hydrothorax as a sole manifestation of congenital parvovirus B19 infection. Am J Perinatol. 2008;25:551-554.
MillerEFairleyCKCohenBJSengC. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105:174-178.
17.
ErgazZOrnoyA. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006;21:421-435.
18.
De JongEPLindenburgITvan KlinkJM. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol. 2012;206:204.e1-204.e5.
19.
DembinskiJHaverkampFMaaraHHansmannMEis-HübingerAMBartmannP. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG. 2002;109:1232-1234.
20.
TiessenRG1van Elsacker-NieleAMVermeij-KeersCOepkesDvan RoosmalenJGorsiraMC. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn. 1994;14:173-176.
21.
WeilandHTVermey-KeersCSalimansMMFleurenGJVerweyRAAndersonMJ. Parvovirus B 19 associated with fetal abnormality. Lancet. 1987;1:682-683.
22.
KochWCAdlerSPHargerJ. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr Infect Dis J. 1993;12:747-750.
23.
DondersGGVan LierdeSVan Elsacker-NieleAMMoermanPGoubauPVandenbergheK. Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis J. 1994;13:234-236.
24.
VeprekováLJelínekJZemanJ. Congenital aplastic anemia caused by parvovirus B19 infection [in Czech]. Cas Lek Cesk. 2001;140:178-180.
25.
Von KaisenbergCSJonatW. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol. 2001;18:280-288.
26.
HsuSTChenYTHuangYF. Prenatal diagnosis and perinatal management of maternal-fetal congenital parvovirus B19 infection. Taiwan J Obstet Gynecol. 2007;46:417-422.
27.
SelbingAJosefssonADahleLOLindgrenR. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet. 1995;345:660-661.
